Shift Work Tied to Disordered Sleeping
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 4, 2024 -- All shift work schedules are associated with adverse sleep effects, according to a study published online Dec. 7 in Frontiers in Psychiatry.
Gretha J. Boersma, Ph.D., from the GGZ Drenthe Mental Health Institute in Assen, Netherlands, and colleagues evaluated the presence of short sleep (no more than six hours) and long sleep (nine or more hours) as well as sleep disorders within a broad range of shift work schedules. The analysis included 37,662 working adults.
The researchers found that all sociodemographic factors examined affected the prevalence rates of short, long, and disordered sleep, consistent with previous studies. Compared with day workers, shift workers more frequently reported short sleep, most prominently night workers (26 versus 50 percent). Among shift workers, all sleep disorders (including insomnia, sleep-related breathing disorders, and sleep-related movement disorders) as well as sleep disorder comorbidity were more common, especially among night workers. Education level had the strongest associations with disturbed sleep among night shift workers, with a twofold higher prevalence of short and disordered sleep in those with low education achievement versus academic-educated groups.
"To prevent sleep curtailment and sleep disorders, employers/occupational health practitioners should encourage good sleep health and give tools to deal with shift work as well as possible, both promoting optimal sleep during the resting period and wakefulness during working hours," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.